Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Needle Stick Clear all
Completed Phase 3 Interventional

Efficacy and Safety of ALGRX 3268 in Children Undergoing Minor Needle-Stick Procedures.

NCT00146185
View directory record Official record
Conditions
Pain
Interventions
ALGRX 3268
Drug
Lead sponsor
AlgoRx Pharmaceuticals
Industry
Eligibility
3 Years to 18 Years
Enrollment
504 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Nov 15, 2005 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Simulated Clinical Use Testing on the DropSafe Safety Pen Needle

NCT03803488
View directory record Official record
Conditions
Needle Stick
Interventions
DropSafe safety pen needle
Device
Lead sponsor
HTL-Strefa S.A.
Industry
Eligibility
18 Years and older
Enrollment
35 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016
U.S. locations
2
States / cities
Golden Valley, Minnesota • Minneapolis, Minnesota
Source: ClinicalTrials.gov public record
Updated Jan 13, 2019 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Phase 3 Interventional

Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.

NCT00140088
View directory record Official record
Conditions
Procedural Pain
Interventions
ALGRX 3268
Drug
Lead sponsor
AlgoRx Pharmaceuticals
Industry
Eligibility
3 Years to 18 Years
Enrollment
504 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2005
U.S. locations
1
States / cities
Hartford, Connecticut
Source: ClinicalTrials.gov public record
Updated Aug 31, 2005 · Synced Jul 21, 2026, 4:40 PM EDT
Withdrawn Phase 4 Interventional

HCV Post-Exposure Prophylaxis for Health Care Workers

NCT03313414
View directory record Official record
Conditions
Hepatitis C
Interventions
Sofosbuvir/Velpatasvir Treatment for 14 days
Drug
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
18 Years and older
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2020
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jan 20, 2020 · Synced Jul 21, 2026, 4:40 PM EDT
Completed No phase listed Observational

Adverse Events in Dry Needling

NCT03612843
View directory record Official record
Conditions
Muscle Soreness, Headache, Knee Osteoarthritis, Back Pain, Neck Pain, Needle Stick, Shoulder Pain, Hip Osteoarthritis
Interventions
Observational dry needle
Other
Lead sponsor
Elizabeth Lane
Other
Eligibility
18 Years to 100 Years
Enrollment
250 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018
U.S. locations
8
States / cities
Acworth, Georgia • Cartersville, Georgia • Fort Oglethorpe, Georgia + 5 more
Source: ClinicalTrials.gov public record
Updated Apr 17, 2019 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

A Trial of Blunt Needles for the Reduction of Needlestick Injuries During Cesarean Section

NCT00844636
View directory record Official record
Conditions
Glove Perforations, Needlestick Injuries
Interventions
Sharp needle, Blunt needles
Device
Lead sponsor
Medical University of South Carolina
Other
Eligibility
18 Years and older · Female only
Enrollment
194 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2005 – 2008
U.S. locations
1
States / cities
Charleston, South Carolina
Source: ClinicalTrials.gov public record
Updated Aug 12, 2018 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Phase 3 Interventional Accepts healthy volunteers

Simulated Clinical Use Testing on Safe'N'Sound 1ML Stalked Passive Delivery System With Add-On Extended Finger Flanges

NCT02663635
View directory record Official record
Conditions
Needle Stick
Interventions
Safe'N'Sound
Device
Lead sponsor
Nemera La Verpilliere
Industry
Eligibility
18 Years and older
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2016
U.S. locations
1
States / cities
Minneapolis, Minnesota
Source: ClinicalTrials.gov public record
Updated Jan 27, 2016 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Phase 2 Interventional Results available

Synera Venipuncture Pain

NCT01744197
View directory record Official record
Conditions
Pain, Phlebotomy, Palliative Care
Interventions
Synera (lidocaine 70mg/tetracaine 70mg)
Drug
Lead sponsor
US Oncology Research
Industry
Eligibility
18 Years and older
Enrollment
61 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Oct 24, 2018 · Synced Jul 21, 2026, 4:40 PM EDT
Recruiting Not applicable Interventional Accepts healthy volunteers

ShotBlocker During Intramuscular Injection Randomized Control Trial

NCT06624176
View directory record Official record
Conditions
Neonatal Pain
Interventions
Bionix ShotBlocker, Swaddling, Sucrose administration, Masimo Rad-97 Oximeter probe
Device · Other
Lead sponsor
Lauren Fortier
Other
Eligibility
37 Weeks to 42 Weeks
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2026
U.S. locations
1
States / cities
Worcester, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jun 3, 2026 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Simulated Clinical Use Testing on Safety Lancets (Test A)

NCT03807635
View directory record Official record
Conditions
Needle Stick
Interventions
ergoLance safety lancet, Acti-Lance safety lancet
Device
Lead sponsor
HTL-Strefa S.A.
Industry
Eligibility
18 Years and older
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018
U.S. locations
2
States / cities
Chicago, Illinois • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jan 21, 2019 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Simulated Clinical Use Testing On Safety Lancets (Test B)

NCT03811444
View directory record Official record
Conditions
Needle Stick
Interventions
Haemolance Plus safety lancet, Prolance safety lancet, MediSafe Solo safety lancet
Device
Lead sponsor
HTL-Strefa S.A.
Industry
Eligibility
18 Years and older
Enrollment
30 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018
U.S. locations
2
States / cities
Chicago, Illinois • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jan 21, 2019 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Phase 2 Interventional

Study of ALGRX 3268 for Needlestick Pain in Children

NCT00132405
View directory record Official record
Conditions
Pain
Interventions
ALGRX 3268
Drug
Lead sponsor
AlgoRx Pharmaceuticals
Industry
Eligibility
3 Years to 18 Years
Enrollment
260 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004
U.S. locations
1
States / cities
Hartford, Connecticut
Source: ClinicalTrials.gov public record
Updated Oct 9, 2005 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test C)

NCT04933461
View directory record Official record
Conditions
Accident Injury
Interventions
Safety lancet
Device
Lead sponsor
HTL-Strefa S.A.
Industry
Eligibility
18 Years and older
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019
U.S. locations
2
States / cities
Chicago, Illinois • Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jun 20, 2021 · Synced Jul 21, 2026, 4:40 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Blunt Needles do Not Reduce Needlestick Injuries to Doctors During Suturing After Child-Birth

NCT00536289
View directory record Official record
Conditions
Needlestick Injuries
Interventions
Blunt needle
Device
Lead sponsor
Medical University of South Carolina
Other
Eligibility
18 Years and older · Female only
Enrollment
438 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2005 – 2006
U.S. locations
1
States / cities
Charleston, South Carolina
Source: ClinicalTrials.gov public record
Updated Sep 26, 2007 · Synced Jul 21, 2026, 4:40 PM EDT
Withdrawn Phase 4 Interventional

Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers

NCT01766115
View directory record Official record
Conditions
Viral Hepatitis C
Interventions
Telaprevir
Drug
Lead sponsor
Massachusetts General Hospital
Other
Eligibility
18 Years to 70 Years
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2014
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Aug 12, 2014 · Synced Jul 21, 2026, 4:40 PM EDT